首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Novel cancer-targeting SPECT/NIRF dual-modality imaging probe 99mTc-PC-1007: Synthesis and biological evaluation
Authors:Yi Zhang  Li Xiao  Kosta Popovic  Xiuzhen Xie  Mahendra D Chordia  Leland WK Chung  Mark B Williams  Wei Yue  Dongfeng Pan
Institution:1. Department of Radiology and Medical Imaging, University of Virginia, Rm 263, 480 Ray C. Hunt Drive, Snyder Building, Charlottesville, VA 22908, USA;2. Uro-Oncology Research, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA;3. Department of Endocrinology and Metabolism, University of Virginia, Charlottesville, VA 22908, USA
Abstract:Synthesis, characterization, in vitro and in vivo biological evaluation of a heptamethine cyanine based dual-mode single-photon emission computed tomography (SPECT)/near infrared fluorescence (NIRF) imaging probe 99mTc-PC-1007 is described. 99mTc-PC-1007 exhibited preferential accumulation in human breast cancer MCF-7 cells. Cancer-specific SPECT/CT and NIRF imaging of 99mTc-PC-1007 was performed in a breast cancer xenograft model. The probe uptake ratio of tumor to control (spinal cord) was calculated to be 4.02 ± 0.56 at 6 h post injection (pi) and 8.50 ± 1.41 at 20 h pi (P < 0.0001). Pharmacokinetic parameters such as blood clearance and organ distribution were assessed.
Keywords:Breast cancer  Dual-modality  Heptamethine cyanine dye  SPECT  99m-Technetium  Near infrared fluorescence
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号